uPMR 790 vs syngo.CT CaScoring

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Shanghai United Imaging Healthcare Co.
VS
by Siemens Medical Solutions USA

AI Verdict

Tool A (uPMR 790) is a comprehensive PET/MR imaging system with AI-enhanced workflows across oncology, neurology, and cardiology, providing high-resolution, simultaneous imaging. Tool B (syngo.CT CaScoring) is a specialized AI-powered software for quantifying and visualizing coronary calcifications from CT scans, focusing specifically on cardiovascular risk assessment. While both offer AI in cardiology, Tool A is a multi-purpose diagnostic hardware system, whereas Tool B is a dedicated software application for CT image analysis.

Choose uPMR 790 if…

Choose the uPMR 790 if your institution requires a comprehensive, high-resolution imaging system capable of simultaneous PET/MRI for advanced clinical diagnostics and cutting-edge research in oncology, neurology, and cardiology. Its large 32cm axial field-of-view and AI-assisted compressed sensing enable faster, more detailed scans for precise lesion detection and advanced research opportunities like simultaneous tracer tracking.

View uPMR 790 →

Choose syngo.CT CaScoring if…

Choose syngo.CT CaScoring if your primary need is rapid, AI-powered quantification and visualization of calcified coronary lesions from CT scans for cardiovascular risk assessment. This software is ideal for integrating with existing Siemens CT scanner systems to quickly calculate Agatston, volume, and calcium mass scores, aiding in prognostic indicators and pre-surgical workups.

View syngo.CT CaScoring →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature uPMR 790 syngo.CT CaScoring
Pricing Not publicly available (high-end medical equipment) Contact for pricing
Deployment On-premise (installed in medical facilities) Integrated with Siemens CT scanner systems; operates as a post-processing application on the multi-user syngo.via client/server platform.
FDA Status Yes AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

uPMR 790

Tool A (uPMR 790) emphasizes intelligent workflow features like automatic positioning, bed planning, and attenuation correction, which can greatly simplify the workflow and reduce the threshold to PET/MR use. Tool B (syngo.CT CaScoring) also offers automated features like highlighting and segmentation, but the overall system integration and comprehensive workflow automation of Tool A suggest a higher degree of usability for complex imaging procedures.

Clinical Value

uPMR 790

Tool A (uPMR 790) provides simultaneous PET/MRI imaging with high temporal and spatial resolution, offering comprehensive imaging for oncology, neurology, and cardiology, including precise detection of subtle lesions and advanced research opportunities. Tool B (syngo.CT CaScoring) focuses on quick quantification and accurate visualization of calcified coronary lesions for cardiovascular risk assessment, which is valuable but more specialized. The broader application and advanced imaging capabilities of Tool A offer a wider range of clinical value.

Pricing & Value

Tie

The pricing for Tool A (uPMR 790) is not publicly available, as it is high-end medical equipment. While Tool B (syngo.CT CaScoring) also requires contacting the vendor for current pricing, a historical list price from 2018 was found, suggesting a one-time license purchase model. Without current and comparable pricing information for both, it is not possible to definitively determine which offers better value.

Enterprise Readiness

syngo.CT CaScoring

Tool B (syngo.CT CaScoring) is integrated with Siemens CT scanner systems and operates on the multi-user syngo.via client/server platform, indicating a design for enterprise-level deployment and scalability. Siemens Healthineers also provides extensive online services, documentation, and support for their products. While Tool A (uPMR 790) is a sophisticated on-premise system, the explicit mention of a multi-user platform and comprehensive enterprise support for Tool B suggests stronger enterprise readiness.

Innovation

uPMR 790

Tool A (uPMR 790) showcases significant innovation with its simultaneous PET/MRI imaging, HD TOF PET platform with digital silicon photomultipliers, industry-leading 2.8 mm NEMA PET spatial resolution, and the uSync Research platform for advanced PET/MR research. These features represent cutting-edge advancements in hybrid imaging technology. Tool B (syngo.CT CaScoring) utilizes AI for image analysis and quantification, which is innovative, but Tool A's integration of multiple advanced imaging modalities and research capabilities demonstrates a higher degree of innovation.

Support & Docs

syngo.CT CaScoring

Siemens Medical Solutions (Tool B) offers a comprehensive support and documentation portal, including a document library for manuals and instructions for use, online services, and various support resources. Shanghai United Imaging Healthcare (Tool A) also provides an online document library and technical support, but the breadth and detail of publicly available support information for Siemens appear more extensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature uPMR 790 syngo.CT CaScoring
Tool Name uPMR 790 syngo.CT CaScoring
Company Shanghai United Imaging Healthcare Co. Siemens Medical Solutions USA
Description The uPMR 790 is Shanghai United Imaging Healthcare Co.'s advanced HD TOF PET/MR system, offering simultaneous, high-resolution imaging with AI-enhanced workflows for clinical and research applications in oncology, neurology, and cardiology. syngo.CT CaScoring by Siemens Medical Solutions USA is an AI-powered image analysis software for quick quantification and accurate visualization of calcified coronary lesions from CT scans, aiding in cardiovascular risk assessment and documentation.
Categories Cardiology AI, Neurology AI, Oncology AI Cardiology AI
Key Features Simultaneous PET/MRI imaging with high temporal and spatial resolution; HD TOF PET platform with digital silicon photomultipliers (SiPMs) and LYSO crystals; Industry-leading 2.8 mm NEMA PET spatial resolution; Large 32cm axial field-of-view (FOV) for comprehensive imaging; United Compressed Sensing (uCSu00ae 2.0) for ultra-fast MR acquisition and high-resolution imaging; Intelligent workflow features including automatic positioning, bed planning, and attenuation correction; uSync Research platform for advanced PET/MR research opportunities; AI-assisted Compressed Sensing (uAIFI ACS) for optimized speed and image quality in MRI Quick quantification of calcified coronary lesions; Accurate visualization of calcified coronary lesions; Calculation of Agatston Score, volume, and calcium mass; Assessment of plaque burden in total and per coronary artery (RCA, LM, LAD, CX); Automatic highlighting of coronary calcifications; User-modifiable threshold for score calculation (default 130 HU); Comparison of patient score to healthy reference groups (e.g., MESA study); Calculation of 'Coronary Age'

Videos

Demos, reviews, and walkthroughs featuring uPMR 790 and syngo.CT CaScoring.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The uPMR 790 offers intelligent workflow features like automatic positioning, bed planning, and attenuation correction to simplify PET/MR use. syngo.CT CaScoring, as a post-processing application on the syngo.via platform, integrates with Siemens CT scanner systems and aims to streamline reporting by structuring results in a machine-readable format for EHR systems.
The uPMR 790 boasts an industry-leading 2.8 mm NEMA PET spatial resolution and high sensitivity, enabling precise detection of subtle lesions for oncology, neurology, and cardiology applications. syngo.CT CaScoring provides accurate quantification and visualization of calcified coronary lesions, calculating Agatston, volume, and calcium mass scores. Studies show excellent agreement between AI and expert CACS with syngo.CT CaScoring, saving approximately 60% of time compared to manual review.
The uPMR 790 aims to reduce the threshold to PET/MR use with intelligent workflow features such as automatic positioning, bed planning, and attenuation correction. syngo.CT CaScoring, as part of the syngo.via platform, is designed to support physicians in evaluating and documenting calcified coronary lesions with features like automatic highlighting and user-modifiable thresholds.
For syngo.CT CaScoring, Siemens Healthineers indicates that upon request, a local representative will clarify system requirements and presumably provide support. While specific details for uPMR 790 support are not provided, its advanced nature suggests comprehensive training and support would be necessary, similar to other high-end medical equipment.
The uPMR 790 system software is used for patient management, data management, scan control, image reconstruction, and image archive, and is designed to conform to DICOM standards. syngo.via, the platform for syngo.CT CaScoring, offers archiving of audit trail logs using optical media or network shares and includes data security and protection measures like firewalls and virus protection.
syngo.via, which hosts syngo.CT CaScoring, includes features for archiving audit trail logs. For the uPMR 790, the system software handles patient and data management, scan control, image reconstruction, and image archiving, and is designed to conform to DICOM standards, which typically include provisions for audit trails.
The uPMR 790 is an advanced HD TOF PET/MR system for oncology, neurology, and cardiology, offering high-resolution imaging for staging, treatment planning, and response assessment, and is also suitable for advanced PET/MR research. syngo.CT CaScoring is specifically designed for cardiovascular risk assessment by quantifying calcified coronary lesions from CT scans, and can be used as a prognostic indicator for atherosclerotic coronary heart disease, including in pre-surgical workups.
AI Tool Finder
AI-powered search. Results may not be comprehensive.